Back
Newmont Corp. 10K Form
Buy
56
NEM
Newmont Corp.
Last Price:
$119.36
Seasonality Move:
3.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | NEM/Newmont Corp. Quarterly |
| 2024-02-29 | 10K | NEM/Newmont Corp. Annual |
| 2023-10-26 | 10Q | NEM/Newmont Corp. Quarterly |
| 2023-07-20 | 10Q | NEM/Newmont Corp. Quarterly |
| 2023-04-27 | 10Q | NEM/Newmont Corp. Quarterly |
| 2023-02-23 | 10K | NEM/Newmont Corp. Annual |
Receive NEM News And Ratings
See the #1 stock for the next 7 days that we like better than NEM
NEM Financial Statistics
Sales & Book Value
| Annual Sales: | $22.1B |
|---|---|
| Cash Flow: | $2.8B |
| Price / Cash Flow: | 18 |
| Annual Sales: | $31.10 |
| Price / Book: | 3.81 |
Profitability
| EPS (TTM): | 6.38590 |
|---|---|
| Net Income (TTM): | $7.2B |
| Gross Margin: | $11B |
| Return on Equity: | 22.22% |
| Return on Assets: | 12.85% |
Newmont Corp. Earnings Forecast
Key Newmont Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for NEM is 49.78%.
-
The Selling, General & Administrative Expenses for NEM have been equal to 1.73% of Gross Profit Margin.
-
The Research & Development expenses have been 0.75% of Revenue.
-
The Interest Expense is 4.20% of Operating Income.
-
The Net Earning history of NEM is 32.43% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 17 years.
Newmont Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | NEM |
| CUSIP: | 651639 |
| Website: | newmont.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 2.29 |
| Quick Ratio: | 1.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.54 |
|---|---|
| Forward P/E Ratio: | 10.95 |
NEM Technical Analysis vs Fundamental Analysis
Buy
56
Newmont Corp. (NEM)
is a Buy
Is Newmont Corp. a Buy or a Sell?
-
Newmont Corp. stock is rated a BuyThe current Newmont Corp. [NEM] share price is $118.52. The Score for NEM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.